1410PTumor mutation burden (TMB) estimation using small-sized targeted next-generation sequencing (NGS) to predict efficacy of immune checkpoint inhibitors (ICIs) for non-small cell lung cancer (NSCLC). (23rd October 2018) - Ikeda, T; Ohashi, K; Sekine, A; Ohe, Y; Tsuda, T; Kataoka, Y; Hara, S; Okamoto, N; Kodani, M; Matsumoto, S; Goto, K